Author: OurCrowd

[SaNOtize in Business Wire] SaNOtize announces $24 million in Series B funding to advance its nitric oxide-based therapeutics, including nasal spray for the treatment and prevention of COVID-19

VANCOUVER, British Columbia–(BUSINESS WIRE)–SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced an oversubscribed $24 million Series B funding to advance its nitric oxide-based therapeutics pipeline. The lead treatment in the pipeline is the company’s nitric oxide nasal spray (NONS™), shown in clinical studies to treat and prevent COVID-19 infection, including a recent Phase 3 study published in The Lancet Regional Health Southeast Asia. The new funding round was co-led by Horizons Ventures and OurCrowd, with participation from ABC International, and enables SaNOtize to expand its research program, including its ongoing global Phase 3 NONS prevention clinical study with plans to recruit up to 3,000 participants in Canada and Sri Lanka. Read more...

Read More

[Orbital Insight in Geospatial World] Thaicom partners with Orbital Insight for a geospatial analytics platform

Thaicom, a satellite communication provider and operator based in Thailand announced on Wednesday that it is partnering up with US-based Orbital Insight Inc. This partnership would enable Thaicom to deliver world-class data insights and intelligence services with Orbital Insight’s geospatial analytics platform to its customers in Thailand and the region. Read...

Read More

[Hub Security in PR Newswire] HUB Files draft prospectus F-4 to the SEC for the upcoming $1.28 billion SPAC Merger and listing of the company’s shares for trading on Nasdaq

TEL AVIV, Israel, Aug 24, 2022 /PRNewswire/ — HUB Cyber Security (Israel) Limited (TASE: HUB), a developer of Confidential Computing cybersecurity solutions and services (“HUB” or the “Company”), announced today that it has officially filed a non-confidential draft registration statement on Form F-4 which contains a preliminary proxy statement/prospectus to the U.S. Securities and Exchange Commission (SEC), for the purpose of completing the merger with the SPAC, the offering of the company’s securities to the shareholders of the SPAC and the start of trading in the company’s securities on Nasdaq. Read more...

Read More